via UC San Francisco
Synthetic Molecules that Adhere Cells Could Galvanize Regenerative Medicine
Researchers at UC San Francisco have engineered molecules that act like “cellular glue,” allowing them to direct in precise fashion how cells bond with each other. The discovery represents a major step toward building tissues and organs, a long-sought goal of regenerative medicine.
Adhesive molecules are found naturally throughout the body, holding its tens of trillions of cells together in highly organized patterns. They form structures, create neuronal circuits and guide immune cells to their targets. Adhesion also facilitates communication between cells to keep the body functioning as a self-regulating whole.
In a new study, published in the Dec. 12, 2022, issue of Nature, researchers engineered cells containing customized adhesion molecules that bound with specific partner cells in predictable ways to form complex multicellular ensembles.
“We were able to engineer cells in a manner that allows us to control which cells they interact with, and also to control the nature of that interaction,” said senior author Wendell Lim, PhD, the Byers Distinguished Professor of Cellular and Molecular Pharmacology and director of UCSF’s Cell Design Institute. “This opens the door to building novel structures like tissues and organs.”
Regenerating Connections Between Cells
Bodily tissues and organs begin to form in utero and continue developing through childhood. By adulthood, many of the molecular instructions that guide these generative processes have disappeared, and some tissues, like nerves, cannot heal from injury or disease.
Lim hopes to overcome this by engineering adult cells to make new connections. But doing this requires an ability to precisely engineer how cells interact with one another.
“The properties of a tissue, like your skin for example, are determined in large part by how the different cells are organized within it,” said Adam Stevens, PhD, the Hartz Fellow in the Cell Design Institute and the first author of the paper. “We’re devising ways to control this organization of cells, which is central to being able to synthesize tissues with the properties we want them to have.”
We’re devising ways to control this organization of cells, which is central to being able to synthesize tissues with the properties we want them to have.
Much of what makes a given tissue distinct is how tightly its cells are bonded together. In a solid organ, like a lung or a liver, many of the cells will be bonded quite tightly. But in the immune system, weaker bonds enable the cells to flow through blood vessels or crawl between the tightly bound cells of skin or organ tissues to reach a pathogen or a wound.
To direct that quality of cell bonding, researchers designed their adhesion molecules in two parts. One part of the molecule acts as a receptor on the outside of the cell and determines which other cells it will interact with. A second part, inside the cell, tunes the strength of the bond that forms. The two parts can be mixed and matched in a modular fashion, creating an array of customized cells that bond in different ways across the spectrum of cell types.
The Code Underlying Cellular Assembly
Stevens said these discoveries also have other applications. For example, researchers could design tissues to model disease states, to make it easier to study them in human tissue.
Cell adhesion was a key development in the evolution of animals and other multicellular organisms, and custom adhesion molecules may offer a deeper understanding of how the path from single to multicellular organisms began.
“It’s very exciting that we now understand much more about how evolution may have started building bodies,” he said. “Our work reveals a flexible molecular adhesion code that determines which cells will interact, and in what way. Now that we are starting to understand it, we can harness this code to direct how cells assemble into tissues and organs. These tools could be really transformative.”
Original Article: Cellular “Glue” to Regenerate Tissues, Heal Wounds, Regrow Nerves
More from: University of California San Francisco | University of California Berkeley
The Latest Updates from Bing News
Go deeper with Bing News on:
Cellular glue
- Allergic Contact Dermatitis from Medical Adhesive Bandages in Patients Who Report Having a Reaction to Medical Bandages
Background: Medical adhesive bandages are extensively used in both inpatient and outpatient medicine. However, few reports describing proven allergic contact dermatitis (ACD) from medical adhesive ...
- Improving perovskite solar cell performance with conductive adhesive ink
Conceived by researchers from Iran, the new conductive adhesive ink is made of polymethyl methacrylate (PMMA) and is used as an interlayer between the cell's hole transport layer and carbon foil. It ...
- The Best Cell Phone Boosters for 2024
Cellular signal boosters use big antennas to improve coverage in your home or car. These are the top cell boosters for apartments, houses, and vehicles. I’m one of PCMag’s mobile analysts ...
- Wi-Fi Calling: How to Use It When There's Not Enough Cellular Signal
If your Wi-Fi network has stronger signal than your cellular carrier, or you're heading somewhere where signal's sparse, you can make calls or texts using the internet. Mike Sorrentino is a Senior ...
- United States Cellular Corp USM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Go deeper with Bing News on:
Engineered cells
- Cross-species liver cell growth could represent a solution to transplant shortage
Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.
- Revolutionary CAR-T cell therapy looks to break through beyond blood cancer
In just a decade, a new treatment has revolutionized the prognosis for people diagnosed with blood cancer. It’s called CAR-T cell therapy, a stunning achievement of genetic engineering that consists ...
- AI predicts tumor-killing cells with high accuracy
Using artificial intelligence, scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.
- Bluebird, Vertex prep for first commercial use of sickle cell gene therapies
A 12-year-old boy in the Washington, D.C., area is set become the first patient treated with Lyfgenia since its U.S. approval last December.
- Engineering Life: Chemists Have Created the Functional Synthetic Cells That Act Like Real Ones
Researchers employ cutting-edge methods to create functional cells, closing the divide between synthetic and biological materials. In a new study published in Nature Chemistry, UNC-Chapel Hill researc ...